hybrid mice, because of complementation which circumvents parental genetic defects, is a suppressor strain and can both produce and accept GT-TsF (12) .
In this paper we report that (nonsuppressor × nonsuppressor)F1 hybrid, (B6 × A)F1
or (BI0.GD × B10.A)FI, mice produce GT-TsF of both parental I-J types. These factors were isolated with immunoadsorbent columns constructed with monoclonal anti-I-J antibodies. The isolated factors were tested for their ability to induce Ts2 in vivo. We found that only one of the GT-specific factors produced by these F1 hybrid mice is able to stimulate the generation of Ts2. This not only demonstrates that these two factors are distinct both serologically and functionally, but also suggests, at least in these complementing Fa hybrids, that distinct H-2-1inked genes may control the production of first-and second-order TsF. generous gift of Dr. Baruj Benacerraf, Harvard Medical School. Poly(Glu -Ala -Tyr 0) (GAT) (lot 1), and MBSA were purchased from Vega Biochemicals, Tucson, AZ. GAT, GT, and their MBSA complexes were prepared as previously described (8) .
Materials and Methods

Animals. BALB/c mice (H-
Antisera. Anti-I-J k alloantisera were prepared by injecting (DBA/ GT-TsF Preparation. GT-TsF was prepared as previously described (6, 12) . Briefly, mice were primed with 100 pg GT in Maalox (aluminum-magnesium hydroxide gel; Wm. Rorer, Fort Washington, PA) intraperitoneally 3-5 d before killing. Single cell suspensions of their spleens were prepared, adjusted to 6 × l0 s cells/ml in Hanks' balanced salt solution (HBSS) and sonicated at 50 W for 5 min by a Sonifier Cell Disrupter (Ultrasonic Industries, Westbury, NY) equipped with a microtip. Sonicated material was centrifuged at 40,000 g for 45 min at 4°C, and the GT-TsF-containing supernatants were stored at -85°C until use.
Immunoadsorbent Columns. Sera and monoclonal antibodies used for the preparation of immunoadsorbent columns were heat-inactivated for 30 rain at 56°C. Immunoadsorbent columns were prepared by coupling the immunoglobulin-rich fraction (precipitated by 50% ammonium sulfate, dissolved, and dialyzed against 0.5M NaC1-0.1M NaHCO3 buffer) to cyanogen bromide (CNBr)-activated Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N J) at 2 mg protein/ml packed gel as previously described (11) . In all cases, coupling efficiency of protein to gel was >90%. Coupled gels were stored in phosphate-buffered saline (PBS) containing 0.02% NaN3 at 4°C until use. Immunoadsorbent columns were prepared by packing 1 ml gel into a 3-ml syringe and exhaustively washing the column with PBS. "Crude" GT-TsF extract (0.1 ml, equivalent to 6 × 107 lymphoid cells) was incubated on the get for 20 min at room temperature. The effluent was collected, the column was washed with 10 volumes of PBS, and the bound protein eluted with 0.I M glycine-HCl buffer, pH 2.5. Eluted material was immediately neutralized to pH 7.2 with a small quantity of 2 M Tris. Concentrations of adsorbed materials are expressed according to original concentrations of factors.
Spleen Cell Cultures. Single cell suspensions of normal BALB/c (H-2 a) spleen cells were aseptically prepared and washed once with HBSS. Cells were resuspended to a final concentration of 16 × 10 cells/ml in Mishell-Dutton medium (13) containing 10-M 2-mercaptoethanol and 10% fetal calf serum (FCS; lot 2851, Pel-Freez Biologicals, Rogers, AR) (11). 2.5 pg GT as GT-MBSA was added to wells of a multiwell culture plate (76-033-05; Linbro Chemical Co., Hamden, CT) each containing 0.5 ml of cell suspension. GT-TsF or column-adsorbed GT-TsF was added to cultures at final concentrations indicated in the table legends. Cultures were incubated for 5 d in a humidifed atmosphere of 83% N2, 10% CO2, and 7% 02 at 37°C. Cultures were fed daily with a mixture of 50% nutritional cocktail and 50% FCS (11) . Induction of Ts2. BALB/c mice were injected intravenously with 0.5 ml of immunoadsorbentpurified GT-TsF (3 X 107 cell equivalents) in the presence of a small amount (50 ng) of GT. The amount of GT added in all cases was at least 200 times less than the minimum tolerogenic dose of GT (9) . 3 d after the injection of factor, mice were killed, their spleens were aseptically removed, single cell suspensions prepared, and 1.5 X 106 of these "factor-primed" cells were added to fresh Mishell-Dutton cultures containing 6.5 X 106 syngeneic spleen cells. GT-MBSA (2.5/~g) was added to appropriate cultures and cells were incubated for 5 d as described above.
Hemolytic Plaque Assay. Cultures were harvested 5 d after initiation, cells were washed three times in HBSS, and plaque-forming cell (PFC) responses were assayed using sheep erythrocytes (SRBC) coupled with the cross-reacting polymer GAT (14) . GT-specific PFC were determined by subtracting the number of PFC detected in the presence of suitable dilution of GAT from the number of PFC detected on GAT-SRBC in the absence of the specific inhibitor. All assays were performed in duplicate and the number of PFC per culture are reported.
Results
Analysis of TsF Produced by Parental and F1 Hybrid
Mice. GT-specific immune suppression is controlled by at least two complementing Is genes (4, 5) . GT-nonsuppressor strains can be divided into either of two categories depending upon which Is gene they lack. Table I summarizes the suppressive characteristics of the parental and F1 hybrid mice used in the present studies. H-2 b or 11-2 g2 haplotype mice cannot be suppressed by GT preimmunization; GT injection results in GT-specific factor production, although these mice are not suppressed by GT-specific factors derived from antigen-primed mice. On the contrary, 1t-2 a haplotype mice are unable to make GT-specific suppressor factors after GT injection, although they are readily suppressed by the appropriate GT-TsF. FI hybrid mice derived from the mating of the two types of nonsuppressor strains are readily suppressed by GT injection, with the concomitant production of GT-specific Ts and GT-TsF. of complementing Is genes derived from the parental strains are suppressed by GT preimmunization (4, 5, 12) . We have also shown that H-2 ~ mice can be suppressed by, although they cannot produce, GT-TsF1, indicating that they lack or have impaired Tsl (6, 8, 12) . H-2 b mice, on the other hand, cannot accept GT-TsF1, although they readily produce GT-TsF upon GT injection, indicating that they lack a suitable target (i.e., pre-Ts2) for GT-TsF1 (12) . (B6 × A)F1 mice, because the abovementioned complementation of Is genes, can both produce and accept GT-TsF1 and hence are GT-suppressor mice (5, 12) . In the present experiments, we confirmed these results using a somewhat different assay scheme. Thus the factors were assayed in vitro using allogeneic BALB/c responding cells (Table II) . In addition, we asked the /-J-type of the resulting Ft GT-TsF. (B6 X A)F1 mice were injected with 100 #g of GT in Maalox, 3 d later their spleens and thymuses were removed, and GT-TsF was extracted from these tissues. The F1 GT-TsF was sequentially adsorbed on anti-I-J k and anti-I-J b alloantisera immunoadsorbent columns. The data shown in Table II show that (B6 × A)F1 GT-TsF suppresses the GT-MBSA PFC responses of BALB/c mice in vitro. A control extract prepared from Maalox-injected (B6 X A)F1 mice is not suppressive, but rather showed an enhancing effect. Adsorption of the F1 GT-TsF on the anti-I-J k columns shows that both the effluent (material not bound by the column) and the eluate of the column are suppressive. To gUard against the possibility that we had merely saturated the column, the effluent from the first (anti-I-J k) column was passed over an anti-I-J b immunoadsorbent. It is apparent from Table II that 1-ff and 1-J b gene products (11) . Ig fractions of the ascites fluids from anti-I-J hybridoma-bearing mice were coupled to CNBr-activated Sepharose 4B at a final protein concentration of 2 mg/ml. An extract derived from GT-primed (B6 × A)F1 mice (GT-TsF) caused nearly total suppression of the GT-MBSA PFC response of BALB/c spleen cells in vitro (Table III) . When (B6 × A)Fx GT-TsF is passaged over a monoclonal anti-I-J k immunoadsorbent column (WF8.C 12.8) both the effluent and and eluate are suppressive. Similar to the result seen in Table II , the effluent from this first column can be shown to contain an I-J b GT-TsF, as is bound to and can be eluted from a monoclonal anti-I-J b immunoadsorbent. Likewise, the acid eluate of the first anti-I-J k column can be shown to contain I-J k but not I-J b GT-TsF, as none of its suppressive activity is bound by WF9.20.8-Sepharose. In subsequent studies, the monoclonal anti-I-J antibodies were used for the preparation of immunoadsorbent columns, as they showed a much clearer separation of I-J b from I-J k GT-TsF derived from these F1 mice.
(
BIO.GD × BIO.A)F1 Mice Produce both I-J k and I-J b GT-TsF.
Mice of the H-2 gu (B 10.GD) and H-2 a (B 10.A) haplotypes are not suppressed by GT preimmunization, although F1 mice derived from these haplotype are suppressed by GT (4). As can be seen from Table IV, the I-Jk-bearing GT-TsF does not induce Ts2. From these data we must conclude that not only are the I-J b and I-J k GT-TsF distinct antigenically, but they have distinct biological activities as well.
B6 GT-TsF Generates GT-TsFe in A/J Mice.
The above data suggest that l-J b and I-J k GT-TsF produced by Fa hybrid mice may act at different cellular levels. Since the I-J b F1 GT-TsF can readily generate Tsz, whereas I-J k Fa GT-TsF cannot, we asked whether I-J b F1 GT-TsF acts by generating Tsz (i.e., it is a GT-TsF1) and if the I-J k F1 GT-TsF is produced by Ts2 (and hence a GT-TsF2). Previous experiments have shown that GT priming of A/J (H-2 a) mice results neither in the generation of Ts nor in the production of GT-TsF. Therefore, B6 GT-TsF1 (extract from GT-primed B6 mice) was injected intravenously into A/J mice in the absence of additional antigen. 5 d later an extract was prepared from the spleens and thymuses of these "factor-primed" mice. Table VII shows that the factor derived from B6 GT-TsFprimed A/J mice (provisionally called GT-TsF2) can readily suppress the GT-MBSA response of BALB/c mice in vitro. That GT-TsF2 is produced by the A/J mouse is demonstrated by the fact that it is bound by a monoclonal anti-I-J k immunoasorbent column (WF8.C12.8) and not by a anti-I-J b immunoadsorbent WF9.40.5), which rules out contamination by B6 GT-TsF1. From these data we conclude that A/J mice, when primed with B6 I-J b GT-TsF, have the ability to produce a second-order suppressor factor (I-J k GT-TsF2). Table VIII shows injection, although they lack a suitable target for this factor (i.e., pre-Ts2). Gene complementation between H-2 a and H-2 b or H-2 g2 nonsuppressor parental strains results in GT-suppressor F1 hybrid mice. In this paper we report that (nonsuppressor X nonsuppressor)Fa hybrid mice produce GT-TsFs of both parental haplotypes. Using monoclonal anti-I-J antibodies that display little or no cross-reactivity between the I-J ~ and I-J k haplotypes (11), we have demonstrated that the l-J b and I-J k antigenic determinants appear on different molecules or molecular complexes. The present studies show that only the I-J b GT-TsF, derived from (nonsuppressor X nonsuppressor)F1 mice, is able to induce Ts2. This is consistent with the observation that injection of B6 [_jb GT-TsF1 plus 50 ng GT into A/J mice results in the production of an antigen-specific I-Jk-bearing GT-TsF2 (12) . The genetic control of GT-specific suppression has been shown to be under the control of two (or more) Is genes, tentatively mapped in the I-A and I-C subregions of the H-2 complex (4, 5) . Our present data demonstrate that GT-specific suppression is a result of the generation of two subsets of Ts and suggest that the genetic defects found in the H-2 ~ and H-2 b mice are at the level of Tsl and Ts2 (or Ts3) cells, respectively. The failure to detect I-Jk-bearing TsF1 in A/J, B10.A, or F1 mice derived from crosses involving these strains (6, 12) suggests that there is a obligate defect in the ability of these mice to produce GT-TsFl-inducing factor with I-J k determinants. This implies that one site of Is gene action is at the Tsl cell or its factor. Furthermore, the present results suggest that the Is gene phenotype is dominant in F1 animals, thus (B6 × A)F1 or (B 10.A × B 10.GD)F1 hybrid mice, like the parental A/J and B 10.A strains, fail to produce an I-Jk-bearing, GT-specific TsFl-inducing factor. Is gene complementation may occur through a different cellular mechanism than was previously observed for Ir gene complementation (15) (16) (17) . In the present system, complementation does not restore the ability to generate I-jk-bearing TsF~-inducing factor, but seems to represent complementation of two distinct genetic defects, i.e., the ability to produce or accept TsFa. This is in sharp contrast to complementation for H-2-1inked Ir genes in which one observes restoration of a common genetic defect in antigen-presenting cells (17) . Furthermore, in accord with previous suggestions (2, 5, 12) , Is gene complementation would require pairing of two distinct H-2-controlled defects involving different cells required for immune suppression. Because it is postulated that both of these cellular defects are controlled by genes of the/-region, one must also postulate that GT-TsF1 which function in these F~ hybrids is not 1t-2 restricted. The ability of I-Jb-derived factors to suppress allogeneic BALB/c (H-2 a) GT-MBSA PFC responses supports this contention.
Specificity of GT-TsFz.
Analysis of T cell function has revealed that antigen-specific immunosuppression is mediated through the interaction of various subsets of suppressor T cells (Tsl, Ts2, Ts3) and their factors (TsFI, TsF2, TsFa). First-and second-order suppressor factors have been reported for the nitrophenyl (NP), azobenzene arsonate (ABA), and keyhole limpet hemocyanin (KLH) suppressor systems (18) (19) (20) . In addition, Ts3 cells and factors have been described in the NP system. The I-Jb-bearing GT-specific factor derived from F1 hybrid mice, in the present study, resembles the GT-TsFa TsF1 as originally defined (8), the I-Jk-bearing GT-TsF appears to differ from the above reported factors in several important respects. The KLH-TsF3, ABA-TsF2, NP-TsF2 and NP-TsF3 are H-2 restricted in their action. The I-Jk-bearing GT-TsF reported in the present study failed to show H-2 restriction as the suppressive activity was assayed in third-party BALB/c (H-2 a, I-J a) mice. The present data also indicate that Igh-V gene restriction is not seen with either GT-TsF factor; in contrast, Igh restriction has been reported for the SRBC-, ABA-, KLH-, and NP-antigen systems (18) (19) (20) (21) . It is important to note that the lack of Vh and H-2 restriction seen in the GT-antigen system may be a result of how the factors are assayed. By assaying TsF activity in allogeneic mice we would not detect H-2-or lgh-restricted factors. Presently, experiments are underway to detect additional GT-TsF which display such genetic restrictions. However, in the GT and GAT antigen systems, all strains of mice appear to produce a similar idiotype (22, 23) and, consequently, one may not be able to detect lgh restriction if the idiotype is nonpolymorphic. An additional reason for lack of H-2 restriction in the GT system, may result from how the factors are prepared. In the present studies, mice were injected with GT 3-5 d before factor preparation. In contrast, the ABA-factor is prepared 7 d after antigen injection (19) , NP-TsF 7 d (18) , and the KLH-TsF is prepared 2 wk after secondary injection with KLH (20) . Differences in the interval between injection of antigen and extraction of factor may result in the preparation of TsF from animals in different immunological states. Different kinetic activities of Ts subsets would help explain why each antigen system would show different restrictions. It may be that the physiological state as well as genotype of the animal may influence which Ts subset(s) predominate after antigen injection, i.e., the longer the interval between antigen injection and factor preparation, the more restricted the suppression.
The administration of microliter quantities of anti-I-J antibodies intravenously to mice has been shown to augment both humoral (24) and cellular (25) immunity, apparently through the inactivation of Ts. We have recently shown that some anti-I-J monoclonal antibodies can augment a humoral immune response although they are unable to bind TsF (11). 1-J gene products have been shown to be expressed on helper T (Th) cells and macrophage subsets as well as Ts (7, 26) . Tada et al. (27) have shown that the 1-J determinant found on Th is distinct from that found on Ts. Collectively, these results suggest a heterogeneity ofI-J gene products. Data presented in the present study suggest that there may be even more heterogeneity within the 1-j subregion than has been heretofore reported with regard to 1-J expression on Ts (7).
We have shown that the (nonsuppressor × nonsuppressor)F1 hybrid mice produce an I-J b (and not an I-J k) GT-TsFx and an I-J k (not an I-J b) GT-TsF2. In addition, we have looked for I-J k GT-TsF1 in concentrations 10-fold greater than those used in the above studies and have seen no suppressive activity. There are several possibilities for this finding; first, the F1 hybrid animal may make GT-TsFs of both parental haplotypes in quantitatively different amounts; our assay may only detect the predominant one in the cell extract. We have produced T cell hybridomas from (nonsuppressor × nonsuppressor)F1 GT-primed mice and are currently exploring this possibility. The second possibility is that I-J b and I-J k gene products are allelically (20, 26, 27) .
Summary
Antigen-specific suppression to poly(GluS°-Tyr ~°) (GT) is under the control of two complementary immune suppressor (Is) genes located in the major histocompatibility (H-2) complex of the mouse. Suppressor strains of mice produce both suppressor T (Ts) ceils and Ts-derived suppressor factors (TsF) that bear antigenic determinants of the I-J subregion of the H-2 complex. Nonsuppressor strains of mice, on the other hand, are not suppressed by GT preimmunization. These nonsuppressor mice, however, can be classified according to those that lack the ability to make GT-specific T cell-derived suppressor factor (GT-TsF) after GT injection (i.e., H-2 ~, l-J k mice) and those that lack the ability to be suppressed by the appropriate GT-TsF (i.e., H-2 b'g2, I-J b mice). In the present study, we demonstrate that (H-2 a X H-2b'g~)F1 hybrid mice produce distinct GT-specific suppressor factors of both parental l-J haplotypes. Moreover, only the I-Jb-bearing GT-TsF derived from these Fa hybrid mice is able to induce second-order suppressor cells (Tsz). This is consistent with the observation that injection of GT-TsF1 derived from C57BL/6 (I-J b) mice into A/J (I-J k) mice leads to the production of an antigen-specific I-J k GT-TsF2. Our results suggest that Is gene complementation occurs through a different cellular mechanism than was previously observed for Ir gene complementation. Further, we show that complementing (nonsuppressor X nonsuppressor)F1 hybrid mice produce an l-J b (and not an I-J k) GTTsF1 and an I-J k (not an I-J b) GT-TsF2, thus suggesting a heterogeneity of Ia loci within the I-J subregion. Data presented in the present study suggest that there may be even more heterogeneity within the I-J subregion than has been heretofore reported with regard to I-J expression on Ts.
